CEL-SCI (NYSE:CVM) Now Covered by Analysts at StockNews.com
StockNews.com started coverage on shares of CEL-SCI (NYSE:CVM – Free Report) in a research note published on Sunday. The brokerage issued a sell rating on the stock. CEL-SCI Price Performance Shares of CVM stock opened at $0.22 on Friday. CEL-SCI has a twelve month low of $0.18 and a twelve month high of $2.39. The […]
More Stories
Tullow Oil (LON:TLW) Stock Price Down 7.6% After Analyst Downgrade
Tullow Oil plc (LON:TLW – Get Free Report) fell 7.6% during mid-day trading on Monday after Shore Capital lowered their...
Tullow Oil (LON:TLW) Stock Price Down 7.6% on Analyst Downgrade
Tullow Oil plc (LON:TLW – Get Free Report)’s stock price dropped 7.6% during trading on Monday after Shore Capital lowered...
Tullow Oil (LON:TLW) Shares Down 7.6% on Analyst Downgrade
Shares of Tullow Oil plc (LON:TLW – Get Free Report) traded down 7.6% on Monday after Shore Capital lowered their...
Head-To-Head Contrast: Avient (NYSE:AVNT) & ASP Isotopes (NASDAQ:ASPI)
Avient (NYSE:AVNT – Get Free Report) and ASP Isotopes (NASDAQ:ASPI – Get Free Report) are both basic materials companies, but...
Innoviva (NASDAQ:INVA) versus Roche (OTCMKTS:RHHBY) Head to Head Review
Innoviva (NASDAQ:INVA – Get Free Report) and Roche (OTCMKTS:RHHBY – Get Free Report) are both medical companies, but which is...
Intellia Therapeutics (NASDAQ:NTLA) Price Target Cut to $60.00 by Analysts at Chardan Capital
Intellia Therapeutics (NASDAQ:NTLA – Get Free Report) had its price objective decreased by equities research analysts at Chardan Capital from...